Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 93

Biotechnology

The  FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients
Biotechnology | COVID-19 | Diagnostics | FDA

The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients

On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…

Read More The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patientsContinue

RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
Biotechnology | FDA | Therapeutics

RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.

On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…

Read More RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.Continue

Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assay
Biotechnology | CDC | COVID-19 | FDA

Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assay

On May 8, 2020, Quidel announced it had received Emergency Use Authorization (EUA) from the FDA to market…

Read More Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assayContinue

Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
Biotechnology | COVID-19 | Diagnostics | Medical Device

Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs

On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…

Read More Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabsContinue

Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms
Biotechnology | COVID-19 | Diagnostics | Genomics | Non-Profit Research | Therapeutics

Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms

On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…

Read More Two groundbreaking drugs could combat COVID-19 and its deadliest symptomsContinue

Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19
Biotechnology | COVID-19 | Therapeutics

Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19

On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…

Read More Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19Continue

OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of  Virus causing COVID-19
Biotechnology | COVID-19 | FDA | Medical Device | Non-Profit Research

OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19

On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…

Read More OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19Continue

First large study of hydroxychloroquine does not support routine use in COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

First large study of hydroxychloroquine does not support routine use in COVID-19 patients

On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…

Read More First large study of hydroxychloroquine does not support routine use in COVID-19 patientsContinue

Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
Biotechnology | COVID-19 | Nanotechnology | Pharmaceutical | Therapeutics | Vaccine

Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine

On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…

Read More Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccineContinue

COVID-19 in-home monitoring program launched
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research

COVID-19 in-home monitoring program launched

On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…

Read More COVID-19 in-home monitoring program launchedContinue

Baxter announced results of clinical trial on benefits of Dynamic Fluid Management in septic shock patients
Biotechnology | Infectious Disease | Influenza | Therapeutics

Baxter announced results of clinical trial on benefits of Dynamic Fluid Management in septic shock patients

On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…

Read More Baxter announced results of clinical trial on benefits of Dynamic Fluid Management in septic shock patientsContinue

Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
Biotechnology | COVID-19 | Medicine | Pharmaceutical | Therapeutics

Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS

On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…

Read More Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDSContinue

Miami University confirmed high quality of IGEA’s COVID-19 rapid test
Biotechnology | COVID-19 | Life Science History

Miami University confirmed high quality of IGEA’s COVID-19 rapid test

On May 6, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…

Read More Miami University confirmed high quality of IGEA’s COVID-19 rapid testContinue

bioMerieux serology tests for SARS-CoV-2 on VIDAS underwent validation preceding launch
Biotechnology | COVID-19

bioMerieux serology tests for SARS-CoV-2 on VIDAS underwent validation preceding launch

On May 6, 2020, bioMerieux announced performance validation and the launch of VIDAS anti-SARS-CoV-2 serology tests to detect…

Read More bioMerieux serology tests for SARS-CoV-2 on VIDAS underwent validation preceding launchContinue

Laurent Pharmaceuticals received Health Canada’s approval to initiate COVID-19 clinical trial
Biotechnology | COVID-19 | Infectious Disease | Pharmaceutical | Therapeutics

Laurent Pharmaceuticals received Health Canada’s approval to initiate COVID-19 clinical trial

On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…

Read More Laurent Pharmaceuticals received Health Canada’s approval to initiate COVID-19 clinical trialContinue

FDA approved first targeted therapy to treat aggressive form of lung cancer
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics

FDA approved first targeted therapy to treat aggressive form of lung cancer

On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…

Read More FDA approved first targeted therapy to treat aggressive form of lung cancerContinue

FDA provided Emergency Use Authorization to PerkinElmer for serological test to identify COVID-19 antibodies
Biotechnology | COVID-19 | Diagnostics | FDA

FDA provided Emergency Use Authorization to PerkinElmer for serological test to identify COVID-19 antibodies

On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…

Read More FDA provided Emergency Use Authorization to PerkinElmer for serological test to identify COVID-19 antibodiesContinue

Tyson Foods Fresh Meats resumed Waterloo, Iowa operations
Agriculture | Biotechnology | COVID-19 | Diagnostics | Infectious Disease | USDA | Vaccine

Tyson Foods Fresh Meats resumed Waterloo, Iowa operations

On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….

Read More Tyson Foods Fresh Meats resumed Waterloo, Iowa operationsContinue

SHERLOCK-based one-step test provided rapid and sensitive COVID-19 detection
Biotechnology | CRISPR | Diagnostics | Infectious Disease

SHERLOCK-based one-step test provided rapid and sensitive COVID-19 detection

On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…

Read More SHERLOCK-based one-step test provided rapid and sensitive COVID-19 detectionContinue

LabCorp announced availability of COVID-19 antibody test
Biotechnology | COVID-19 | Medical Device

LabCorp announced availability of COVID-19 antibody test

On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…

Read More LabCorp announced availability of COVID-19 antibody testContinue

Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19
Biotechnology | COVID-19 | FDA | Genomics | Infectious Disease | Therapeutics

Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19

On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…

Read More Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19Continue

Anixa Biosciences and OntoChem announced discovery of first Covid-19 therapeutic candidate
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Anixa Biosciences and OntoChem announced discovery of first Covid-19 therapeutic candidate

On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…

Read More Anixa Biosciences and OntoChem announced discovery of first Covid-19 therapeutic candidateContinue

Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research | Therapeutics

Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program

On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…

Read More Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access programContinue

DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
Biotechnology | Diagnostics | FDA | Medical Device

DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test

On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…

Read More DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 testContinue

USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
Biotechnology | COVID-19 | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics

USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies

On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…

Read More USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologiesContinue

BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use Authorization
Biotechnology | COVID-19 | FDA

BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use Authorization

On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…

Read More BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use AuthorizationContinue

AbCellera identified antibodies for potential use in drugs to treat and prevent COVID-19
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics

AbCellera identified antibodies for potential use in drugs to treat and prevent COVID-19

On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…

Read More AbCellera identified antibodies for potential use in drugs to treat and prevent COVID-19Continue

Roche’s COVID-19 antibody test received FDA Emergency Use Authorization and is available in markets accepting the CE mark
Biotechnology | FDA

Roche’s COVID-19 antibody test received FDA Emergency Use Authorization and is available in markets accepting the CE mark

On May 2, 2020, Roche announced that the FDA has issued an Emergency Use Authorization for its new…

Read More Roche’s COVID-19 antibody test received FDA Emergency Use Authorization and is available in markets accepting the CE markContinue

USC study showed Alzheimer’s gene triggers early breakdowns in the blood-brain barrier, predicting cognitive decline
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

USC study showed Alzheimer’s gene triggers early breakdowns in the blood-brain barrier, predicting cognitive decline

On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…

Read More USC study showed Alzheimer’s gene triggers early breakdowns in the blood-brain barrier, predicting cognitive declineContinue

US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19

On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…

Read More US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19Continue

Page navigation

Previous PagePrevious 1 … 91 92 93 94 95 … 173 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search